

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.69569324 |
| 2 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.23557304 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 4.06393590 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 4.06393590 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.06393590 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.06393590 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.06393590 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.06393590 |
| 9 | protein targeting to Golgi (GO:0000042) | 3.91670918 |
| 10 | positive regulation of protein autophosphorylation (GO:0031954) | 3.70636592 |
| 11 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.63617650 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.50736933 |
| 13 | growth hormone receptor signaling pathway (GO:0060396) | 3.47809882 |
| 14 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.45811747 |
| 15 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.41845578 |
| 16 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.29966435 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 3.28511179 |
| 18 | cell adhesion mediated by integrin (GO:0033627) | 3.27496555 |
| 19 | positive regulation of p38MAPK cascade (GO:1900745) | 3.26032735 |
| 20 | positive regulation of heat generation (GO:0031652) | 3.19683429 |
| 21 | positive regulation of interferon-alpha production (GO:0032727) | 3.13659797 |
| 22 | smooth muscle tissue development (GO:0048745) | 3.13352609 |
| 23 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.07174594 |
| 24 | regulation of interferon-alpha production (GO:0032647) | 3.06463952 |
| 25 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.05742505 |
| 26 | collagen fibril organization (GO:0030199) | 3.04515724 |
| 27 | protein localization to Golgi apparatus (GO:0034067) | 3.03780850 |
| 28 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.97921802 |
| 29 | positive regulation of muscle hypertrophy (GO:0014742) | 2.97921802 |
| 30 | prostate gland growth (GO:0060736) | 2.97432482 |
| 31 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.97175364 |
| 32 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.96895091 |
| 33 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.96459241 |
| 34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.93943829 |
| 35 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.93159086 |
| 36 | macrophage activation involved in immune response (GO:0002281) | 2.91487517 |
| 37 | cellular response to growth hormone stimulus (GO:0071378) | 2.90000824 |
| 38 | macroautophagy (GO:0016236) | 2.89697049 |
| 39 | regulation of hexokinase activity (GO:1903299) | 2.88379779 |
| 40 | regulation of glucokinase activity (GO:0033131) | 2.88379779 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.88011763 |
| 42 | interkinetic nuclear migration (GO:0022027) | 2.87980390 |
| 43 | I-kappaB phosphorylation (GO:0007252) | 2.86903867 |
| 44 | Golgi to endosome transport (GO:0006895) | 2.78837189 |
| 45 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.78337017 |
| 46 | negative regulation of lipid storage (GO:0010888) | 2.77624865 |
| 47 | protein localization to endosome (GO:0036010) | 2.73977584 |
| 48 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.73030112 |
| 49 | regulation of mononuclear cell migration (GO:0071675) | 2.72035310 |
| 50 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.71474122 |
| 51 | COPII vesicle coating (GO:0048208) | 2.71370029 |
| 52 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.71031980 |
| 53 | regulation of Rac protein signal transduction (GO:0035020) | 2.69981616 |
| 54 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.69947141 |
| 55 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.69512608 |
| 56 | pericardium development (GO:0060039) | 2.68688060 |
| 57 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.66712932 |
| 58 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.65903225 |
| 59 | regulation of DNA endoreduplication (GO:0032875) | 2.65864932 |
| 60 | natural killer cell mediated immunity (GO:0002228) | 2.65842603 |
| 61 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.65842603 |
| 62 | regulation of fever generation (GO:0031620) | 2.65240890 |
| 63 | positive regulation of bone resorption (GO:0045780) | 2.65199358 |
| 64 | positive regulation of bone remodeling (GO:0046852) | 2.65199358 |
| 65 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.64295298 |
| 66 | negative regulation of protein localization to cell surface (GO:2000009) | 2.63396710 |
| 67 | chondrocyte proliferation (GO:0035988) | 2.62280608 |
| 68 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.59897488 |
| 69 | response to host immune response (GO:0052572) | 2.59897488 |
| 70 | protein localization to cell surface (GO:0034394) | 2.58605655 |
| 71 | apoptotic cell clearance (GO:0043277) | 2.58386569 |
| 72 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.56914009 |
| 73 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.56366014 |
| 74 | response to muramyl dipeptide (GO:0032495) | 2.56209561 |
| 75 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.54778071 |
| 76 | modulation by symbiont of host cellular process (GO:0044068) | 2.54646270 |
| 77 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.53594940 |
| 78 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.51733635 |
| 79 | protein prenylation (GO:0018342) | 2.50950971 |
| 80 | prenylation (GO:0097354) | 2.50950971 |
| 81 | blood vessel maturation (GO:0001955) | 2.50235949 |
| 82 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.50176384 |
| 83 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.50133453 |
| 84 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.49115934 |
| 85 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.48471245 |
| 86 | regulation of sarcomere organization (GO:0060297) | 2.47627058 |
| 87 | keratinocyte development (GO:0003334) | 2.47078167 |
| 88 | regulation of muscle hypertrophy (GO:0014743) | 2.46179620 |
| 89 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.46142545 |
| 90 | metanephric mesenchyme development (GO:0072075) | 2.45637910 |
| 91 | negative regulation of complement activation (GO:0045916) | 2.44805865 |
| 92 | face morphogenesis (GO:0060325) | 2.43975124 |
| 93 | glomerular visceral epithelial cell development (GO:0072015) | 2.43910275 |
| 94 | wound healing, spreading of epidermal cells (GO:0035313) | 2.43540735 |
| 95 | regulation of establishment of cell polarity (GO:2000114) | 2.43515627 |
| 96 | lymphangiogenesis (GO:0001946) | 2.43467592 |
| 97 | artery development (GO:0060840) | 2.43265827 |
| 98 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.43050463 |
| 99 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.41395905 |
| 100 | response to host (GO:0075136) | 2.39476387 |
| 101 | response to host defenses (GO:0052200) | 2.39476387 |
| 102 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.39476387 |
| 103 | hemidesmosome assembly (GO:0031581) | 2.39143762 |
| 104 | positive regulation of glycolytic process (GO:0045821) | 2.38798597 |
| 105 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.38706949 |
| 106 | phospholipid homeostasis (GO:0055091) | 2.37652162 |
| 107 | fibroblast migration (GO:0010761) | 2.36434928 |
| 108 | desmosome organization (GO:0002934) | 2.35633555 |
| 109 | response to peptidoglycan (GO:0032494) | 2.35483069 |
| 110 | positive regulation of humoral immune response (GO:0002922) | 2.31847795 |
| 111 | positive regulation of interferon-beta production (GO:0032728) | 2.31544405 |
| 112 | low-density lipoprotein particle clearance (GO:0034383) | 2.30885079 |
| 113 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.30423998 |
| 114 | nucleus localization (GO:0051647) | 2.30231675 |
| 115 | genitalia morphogenesis (GO:0035112) | 2.29566272 |
| 116 | regulation of heat generation (GO:0031650) | 2.29528551 |
| 117 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.28604726 |
| 118 | kidney mesenchyme development (GO:0072074) | 2.27609570 |
| 119 | lipoprotein transport (GO:0042953) | 2.27300971 |
| 120 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.26908458 |
| 121 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.26358652 |
| 122 | regulation of cholesterol storage (GO:0010885) | 2.26063258 |
| 123 | mitotic sister chromatid cohesion (GO:0007064) | 2.25954284 |
| 124 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.25418179 |
| 125 | negative regulation of cell killing (GO:0031342) | 2.24863388 |
| 126 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.24863388 |
| 127 | negative regulation of hormone metabolic process (GO:0032351) | 2.24507332 |
| 128 | phospholipid translocation (GO:0045332) | 2.24227403 |
| 129 | lipid translocation (GO:0034204) | 2.24227403 |
| 130 | regulation of keratinocyte proliferation (GO:0010837) | 2.23254748 |
| 131 | positive regulation of macrophage differentiation (GO:0045651) | 2.22653620 |
| 132 | myeloid cell activation involved in immune response (GO:0002275) | 2.22441198 |
| 133 | negative regulation of protein activation cascade (GO:2000258) | 2.22111043 |
| 134 | positive regulation of lipid storage (GO:0010884) | 2.21550616 |
| 135 | regulation of protein glycosylation (GO:0060049) | 2.19315282 |
| 136 | regulation of protein polyubiquitination (GO:1902914) | 2.19117004 |
| 137 | granulocyte activation (GO:0036230) | 2.18958205 |
| 138 | glomerular basement membrane development (GO:0032836) | 2.18421290 |
| 139 | endocardial cushion development (GO:0003197) | 2.17752310 |
| 140 | microglial cell activation (GO:0001774) | 2.17525966 |
| 141 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.17276357 |
| 142 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.16401464 |
| 143 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.16099514 |
| 144 | macrophage activation (GO:0042116) | 2.16038899 |
| 145 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.15768111 |
| 146 | regulation of protein autophosphorylation (GO:0031952) | 2.15516990 |
| 147 | cellular response to interferon-alpha (GO:0035457) | 2.15322894 |
| 148 | cellular response to ethanol (GO:0071361) | 2.15305708 |
| 149 | regulation of muscle adaptation (GO:0043502) | 2.15151176 |
| 150 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.15095739 |
| 151 | detection of calcium ion (GO:0005513) | 2.15079285 |
| 152 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.14389654 |
| 153 | T-helper 1 type immune response (GO:0042088) | 2.14259178 |
| 154 | germinal center formation (GO:0002467) | 2.13654990 |
| 155 | response to redox state (GO:0051775) | 2.13511176 |
| 156 | lung lobe morphogenesis (GO:0060463) | 2.12730785 |
| 157 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.12622308 |
| 158 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.12011071 |
| 159 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.11529132 |
| 160 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.11304731 |
| 161 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.11304731 |
| 162 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.11304731 |
| 163 | ovulation from ovarian follicle (GO:0001542) | 2.11299461 |
| 164 | regulation of integrin activation (GO:0033623) | 2.11292633 |
| 165 | positive regulation of fibroblast migration (GO:0010763) | 2.11233207 |
| 166 | anterior/posterior axis specification, embryo (GO:0008595) | 2.11037095 |
| 167 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.10758847 |
| 168 | vascular smooth muscle contraction (GO:0014829) | 2.10504604 |
| 169 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.09706203 |
| 170 | lipid particle organization (GO:0034389) | 2.09405398 |
| 171 | neutrophil mediated immunity (GO:0002446) | 2.09370330 |
| 172 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.09184157 |
| 173 | hippo signaling (GO:0035329) | 2.08650515 |
| 174 | regulation of skeletal muscle contraction (GO:0014819) | 2.08518269 |
| 175 | response to pheromone (GO:0019236) | 2.07329664 |
| 176 | regulation of meiosis I (GO:0060631) | 2.06554221 |
| 177 | * early endosome to late endosome transport (GO:0045022) | 2.06301675 |
| 178 | keratan sulfate catabolic process (GO:0042340) | 2.06023412 |
| 179 | magnesium ion transport (GO:0015693) | 2.05097165 |
| 180 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.05075749 |
| 181 | photoreceptor cell differentiation (GO:0046530) | 2.05024187 |
| 182 | eye photoreceptor cell differentiation (GO:0001754) | 2.05024187 |
| 183 | establishment of protein localization to vacuole (GO:0072666) | 2.04973941 |
| 184 | protein targeting to vacuole (GO:0006623) | 2.04973941 |
| 185 | myeloid dendritic cell differentiation (GO:0043011) | 2.04916212 |
| 186 | positive regulation of interleukin-1 production (GO:0032732) | 2.04807835 |
| 187 | JAK-STAT cascade (GO:0007259) | 2.03536734 |
| 188 | neutrophil activation (GO:0042119) | 2.03074671 |
| 189 | positive regulation of interleukin-12 production (GO:0032735) | 2.01195858 |
| 190 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.01080048 |
| 191 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.00098696 |
| 192 | cytokine secretion (GO:0050663) | 1.98855000 |
| 193 | detection of molecule of bacterial origin (GO:0032490) | 1.97339850 |
| 194 | plasma membrane repair (GO:0001778) | 1.97119314 |
| 195 | establishment of protein localization to Golgi (GO:0072600) | 1.95876066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.40226551 |
| 2 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.18766850 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.93039659 |
| 4 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.84659764 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.78700488 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.74894592 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.65745862 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.61336089 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.53021421 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.51591441 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28253477 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.27792348 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.23608148 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.19378436 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.18124750 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.15793843 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06770617 |
| 18 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.05743197 |
| 19 | FUS_26573619_Chip-Seq_HEK293_Human | 2.04586238 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.03098372 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.00831854 |
| 22 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.98823493 |
| 23 | P300_19829295_ChIP-Seq_ESCs_Human | 1.91554044 |
| 24 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.87918052 |
| 25 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.84242543 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81981872 |
| 27 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.80502160 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.77697869 |
| 29 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.71202540 |
| 30 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.71202540 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.69968293 |
| 32 | EWS_26573619_Chip-Seq_HEK293_Human | 1.67912436 |
| 33 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.67166609 |
| 34 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.66369909 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60965099 |
| 36 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.60409820 |
| 37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.59662099 |
| 38 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.59637282 |
| 39 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.58697555 |
| 40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.57612838 |
| 41 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.56456081 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55183051 |
| 43 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.55044324 |
| 44 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.54364778 |
| 45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.51499479 |
| 46 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.49830015 |
| 47 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.49310132 |
| 48 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48634705 |
| 49 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.48086355 |
| 50 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.47657097 |
| 51 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47231146 |
| 52 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.46663710 |
| 53 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.46137858 |
| 54 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.45799166 |
| 55 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.45324168 |
| 56 | TCF4_23295773_ChIP-Seq_U87_Human | 1.45314758 |
| 57 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.42781401 |
| 58 | VDR_22108803_ChIP-Seq_LS180_Human | 1.41290049 |
| 59 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.40410851 |
| 60 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39249197 |
| 61 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39249197 |
| 62 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.38060974 |
| 63 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37690346 |
| 64 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.36549979 |
| 65 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.35020365 |
| 66 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.34223283 |
| 67 | RXR_22108803_ChIP-Seq_LS180_Human | 1.33772493 |
| 68 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.33460791 |
| 69 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.33347404 |
| 70 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.32278343 |
| 71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32114819 |
| 72 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.31144721 |
| 73 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.29216543 |
| 74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28067368 |
| 75 | GATA1_22025678_ChIP-Seq_K562_Human | 1.27048587 |
| 76 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.26660848 |
| 77 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26251855 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26250901 |
| 79 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.25747858 |
| 80 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.24758445 |
| 81 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.24099710 |
| 82 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.24008844 |
| 83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23807927 |
| 84 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.22685856 |
| 85 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.21652246 |
| 86 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21236387 |
| 87 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.20568762 |
| 88 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.19265751 |
| 89 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18861723 |
| 90 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18861723 |
| 91 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17987419 |
| 92 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.17238101 |
| 93 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.15806278 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15708494 |
| 95 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15370159 |
| 96 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15207167 |
| 97 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.14233291 |
| 98 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13802463 |
| 99 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.13473293 |
| 100 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12529210 |
| 101 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.11965961 |
| 102 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11929084 |
| 103 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.11833243 |
| 104 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11523047 |
| 105 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10957129 |
| 106 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.10857959 |
| 107 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10126459 |
| 108 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.09806218 |
| 109 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.08832089 |
| 110 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.08821566 |
| 111 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.08311419 |
| 112 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08281417 |
| 113 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.07925130 |
| 114 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07811714 |
| 115 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.07732095 |
| 116 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07402579 |
| 117 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07375287 |
| 118 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.07232040 |
| 119 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.07181134 |
| 120 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06760132 |
| 121 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06621245 |
| 122 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.06519892 |
| 123 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.06062123 |
| 124 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.05024182 |
| 125 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04993144 |
| 126 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04719703 |
| 127 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04588471 |
| 128 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.04541332 |
| 129 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.03512995 |
| 130 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.03040121 |
| 131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02885609 |
| 132 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.02585924 |
| 133 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02560114 |
| 134 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.00896284 |
| 135 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98965362 |
| 136 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97950627 |
| 137 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97430307 |
| 138 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96848210 |
| 139 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96758167 |
| 140 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95997633 |
| 141 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95974705 |
| 142 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94798340 |
| 143 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.94388980 |
| 144 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90424746 |
| 145 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90041395 |
| 146 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88967832 |
| 147 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.88957648 |
| 148 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.88836199 |
| 149 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88654766 |
| 150 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87939372 |
| 151 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.87844318 |
| 152 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87549982 |
| 153 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.87447109 |
| 154 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87436539 |
| 155 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.86564624 |
| 156 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85116793 |
| 157 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83265404 |
| 158 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83030709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.25749913 |
| 2 | MP0003300_gastrointestinal_ulcer | 3.53296330 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.49217884 |
| 4 | MP0003303_peritoneal_inflammation | 3.04188672 |
| 5 | MP0005503_abnormal_tendon_morphology | 2.96441129 |
| 6 | MP0006054_spinal_hemorrhage | 2.82579288 |
| 7 | MP0003436_decreased_susceptibility_to | 2.67255246 |
| 8 | MP0004272_abnormal_basement_membrane | 2.50386788 |
| 9 | MP0002877_abnormal_melanocyte_morpholog | 2.47807920 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.47787378 |
| 11 | MP0004510_myositis | 2.38453682 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.38329402 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.34044013 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.22470750 |
| 15 | MP0005076_abnormal_cell_differentiation | 2.13230805 |
| 16 | MP0000013_abnormal_adipose_tissue | 2.06666971 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 1.92385099 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 1.92050709 |
| 19 | MP0002419_abnormal_innate_immunity | 1.88791638 |
| 20 | MP0008057_abnormal_DNA_replication | 1.87624860 |
| 21 | MP0002166_altered_tumor_susceptibility | 1.87340362 |
| 22 | MP0001790_abnormal_immune_system | 1.84157947 |
| 23 | MP0005387_immune_system_phenotype | 1.84157947 |
| 24 | MP0002006_tumorigenesis | 1.83446891 |
| 25 | MP0003279_aneurysm | 1.83020904 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.81957666 |
| 27 | MP0006082_CNS_inflammation | 1.79888864 |
| 28 | MP0004084_abnormal_cardiac_muscle | 1.77082146 |
| 29 | MP0004947_skin_inflammation | 1.76948173 |
| 30 | MP0000604_amyloidosis | 1.75859559 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.70940998 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.69469393 |
| 33 | MP0003252_abnormal_bile_duct | 1.68639809 |
| 34 | MP0003045_fibrosis | 1.68400070 |
| 35 | MP0003091_abnormal_cell_migration | 1.68165763 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.66963196 |
| 37 | MP0004215_abnormal_myocardial_fiber | 1.66232856 |
| 38 | MP0003724_increased_susceptibility_to | 1.64770588 |
| 39 | MP0003941_abnormal_skin_development | 1.62904653 |
| 40 | MP0002998_abnormal_bone_remodeling | 1.59759472 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.58203403 |
| 42 | MP0002295_abnormal_pulmonary_circulatio | 1.56009767 |
| 43 | MP0000749_muscle_degeneration | 1.55358035 |
| 44 | MP0002254_reproductive_system_inflammat | 1.54216877 |
| 45 | MP0009785_altered_susceptibility_to | 1.53952750 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.50508122 |
| 47 | MP0003195_calcinosis | 1.49004885 |
| 48 | MP0005671_abnormal_response_to | 1.47917920 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.45617551 |
| 50 | MP0003448_altered_tumor_morphology | 1.45243420 |
| 51 | MP0005275_abnormal_skin_tensile | 1.43422641 |
| 52 | MP0005248_abnormal_Harderian_gland | 1.40920506 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.40886246 |
| 54 | MP0002108_abnormal_muscle_morphology | 1.39554287 |
| 55 | MP0003890_abnormal_embryonic-extraembry | 1.39466339 |
| 56 | MP0005025_abnormal_response_to | 1.38503333 |
| 57 | MP0005171_absent_coat_pigmentation | 1.36660391 |
| 58 | MP0001800_abnormal_humoral_immune | 1.34893633 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.34377097 |
| 60 | MP0010307_abnormal_tumor_latency | 1.33546377 |
| 61 | MP0002060_abnormal_skin_morphology | 1.33411113 |
| 62 | MP0000685_abnormal_immune_system | 1.33273701 |
| 63 | MP0004134_abnormal_chest_morphology | 1.32714364 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.32663370 |
| 65 | MP0009384_cardiac_valve_regurgitation | 1.31238835 |
| 66 | MP0001542_abnormal_bone_strength | 1.28928745 |
| 67 | MP0002723_abnormal_immune_serum | 1.28884072 |
| 68 | MP0000383_abnormal_hair_follicle | 1.28400114 |
| 69 | MP0009764_decreased_sensitivity_to | 1.26904772 |
| 70 | MP0009780_abnormal_chondrocyte_physiolo | 1.26720559 |
| 71 | MP0005379_endocrine/exocrine_gland_phen | 1.24639821 |
| 72 | MP0001879_abnormal_lymphatic_vessel | 1.24058993 |
| 73 | MP0008877_abnormal_DNA_methylation | 1.23977675 |
| 74 | MP0005464_abnormal_platelet_physiology | 1.23866227 |
| 75 | MP0005408_hypopigmentation | 1.23338439 |
| 76 | MP0005187_abnormal_penis_morphology | 1.22665766 |
| 77 | MP0003787_abnormal_imprinting | 1.22169278 |
| 78 | MP0001299_abnormal_eye_distance/ | 1.20208085 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.19705587 |
| 80 | MP0004036_abnormal_muscle_relaxation | 1.18224294 |
| 81 | MP0005310_abnormal_salivary_gland | 1.17726347 |
| 82 | MP0005623_abnormal_meninges_morphology | 1.17028959 |
| 83 | MP0000751_myopathy | 1.16734962 |
| 84 | MP0002168_other_aberrant_phenotype | 1.14805251 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 1.14119516 |
| 86 | MP0001851_eye_inflammation | 1.14034241 |
| 87 | MP0004130_abnormal_muscle_cell | 1.13702806 |
| 88 | MP0001958_emphysema | 1.11469595 |
| 89 | MP0009278_abnormal_bone_marrow | 1.11195238 |
| 90 | MP0001853_heart_inflammation | 1.10587991 |
| 91 | MP0003385_abnormal_body_wall | 1.10457362 |
| 92 | MP0005360_urolithiasis | 1.10100644 |
| 93 | MP0002009_preneoplasia | 1.07611384 |
| 94 | MP0010155_abnormal_intestine_physiology | 1.06769900 |
| 95 | MP0002102_abnormal_ear_morphology | 1.05803433 |
| 96 | MP0000647_abnormal_sebaceous_gland | 1.05456091 |
| 97 | MP0010368_abnormal_lymphatic_system | 1.05304257 |
| 98 | MP0002405_respiratory_system_inflammati | 1.05162378 |
| 99 | MP0002896_abnormal_bone_mineralization | 1.03668380 |
| 100 | MP0001819_abnormal_immune_cell | 1.03538207 |
| 101 | MP0010386_abnormal_urinary_bladder | 1.03179743 |
| 102 | MP0003755_abnormal_palate_morphology | 1.02822408 |
| 103 | MP0005174_abnormal_tail_pigmentation | 1.01912703 |
| 104 | MP0002420_abnormal_adaptive_immunity | 1.01625295 |
| 105 | MP0002928_abnormal_bile_duct | 1.00849945 |
| 106 | MP0001984_abnormal_olfaction | 1.00451432 |
| 107 | MP0009250_abnormal_appendicular_skeleto | 0.98929950 |
| 108 | MP0005365_abnormal_bile_salt | 0.98408529 |
| 109 | MP0009046_muscle_twitch | 0.97919809 |
| 110 | MP0006072_abnormal_retinal_apoptosis | 0.97665785 |
| 111 | MP0003795_abnormal_bone_structure | 0.97395426 |
| 112 | MP0002233_abnormal_nose_morphology | 0.96031528 |
| 113 | MP0003075_altered_response_to | 0.95584173 |
| 114 | MP0001881_abnormal_mammary_gland | 0.94576637 |
| 115 | MP0008469_abnormal_protein_level | 0.94233087 |
| 116 | MP0000003_abnormal_adipose_tissue | 0.92990982 |
| 117 | MP0005620_abnormal_muscle_contractility | 0.92851502 |
| 118 | MP0004484_altered_response_of | 0.92766205 |
| 119 | MP0003937_abnormal_limbs/digits/tail_de | 0.90587510 |
| 120 | MP0005023_abnormal_wound_healing | 0.90455751 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 0.90399505 |
| 122 | MP0002909_abnormal_adrenal_gland | 0.90276933 |
| 123 | MP0003121_genomic_imprinting | 0.89403168 |
| 124 | MP0008775_abnormal_heart_ventricle | 0.89124614 |
| 125 | MP0003868_abnormal_feces_composition | 0.88831214 |
| 126 | MP0005397_hematopoietic_system_phenotyp | 0.88406121 |
| 127 | MP0001545_abnormal_hematopoietic_system | 0.88406121 |
| 128 | MP0010678_abnormal_skin_adnexa | 0.87940221 |
| 129 | MP0005508_abnormal_skeleton_morphology | 0.87679379 |
| 130 | MP0005451_abnormal_body_composition | 0.87261633 |
| 131 | MP0000627_abnormal_mammary_gland | 0.87240791 |
| 132 | MP0002160_abnormal_reproductive_system | 0.85643973 |
| 133 | MP0000427_abnormal_hair_cycle | 0.85374161 |
| 134 | MP0003935_abnormal_craniofacial_develop | 0.84575783 |
| 135 | MP0005390_skeleton_phenotype | 0.84526062 |
| 136 | MP0002139_abnormal_hepatobiliary_system | 0.84089708 |
| 137 | MP0000609_abnormal_liver_physiology | 0.83667057 |
| 138 | MP0009763_increased_sensitivity_to | 0.82076379 |
| 139 | MP0005166_decreased_susceptibility_to | 0.82020069 |
| 140 | MP0000372_irregular_coat_pigmentation | 0.81895914 |
| 141 | MP0002933_joint_inflammation | 0.81698472 |
| 142 | MP0009697_abnormal_copulation | 0.81266193 |
| 143 | MP0000428_abnormal_craniofacial_morphol | 0.80848673 |
| 144 | MP0001216_abnormal_epidermal_layer | 0.80770862 |
| 145 | MP0000733_abnormal_muscle_development | 0.80615921 |
| 146 | MP0000015_abnormal_ear_pigmentation | 0.80524704 |
| 147 | MP0000767_abnormal_smooth_muscle | 0.80433238 |
| 148 | MP0002269_muscular_atrophy | 0.79895509 |
| 149 | MP0000432_abnormal_head_morphology | 0.78290283 |
| 150 | MP0001243_abnormal_dermal_layer | 0.77724281 |
| 151 | MP0003828_pulmonary_edema | 0.75055660 |
| 152 | MP0004185_abnormal_adipocyte_glucose | 0.74928300 |
| 153 | MP0005253_abnormal_eye_physiology | 0.74010002 |
| 154 | MP0005551_abnormal_eye_electrophysiolog | 0.73558050 |
| 155 | MP0000371_diluted_coat_color | 0.73535979 |
| 156 | MP0002693_abnormal_pancreas_physiology | 0.73116667 |
| 157 | MP0000249_abnormal_blood_vessel | 0.73094307 |
| 158 | MP0004043_abnormal_pH_regulation | 0.72156056 |
| 159 | MP0002938_white_spotting | 0.71648925 |
| 160 | MP0005369_muscle_phenotype | 0.71608949 |
| 161 | MP0002177_abnormal_outer_ear | 0.71309248 |
| 162 | MP0002876_abnormal_thyroid_physiology | 0.71226092 |
| 163 | MP0005083_abnormal_biliary_tract | 0.71032215 |
| 164 | MP0000343_altered_response_to | 0.69841478 |
| 165 | MP0000516_abnormal_urinary_system | 0.68619147 |
| 166 | MP0005367_renal/urinary_system_phenotyp | 0.68619147 |
| 167 | MP0004085_abnormal_heartbeat | 0.68482697 |
| 168 | MP0005595_abnormal_vascular_smooth | 0.67858546 |
| 169 | MP0000462_abnormal_digestive_system | 0.67812461 |
| 170 | MP0002127_abnormal_cardiovascular_syste | 0.67733899 |
| 171 | MP0002972_abnormal_cardiac_muscle | 0.67255956 |
| 172 | MP0000613_abnormal_salivary_gland | 0.66648256 |
| 173 | MP0002128_abnormal_blood_circulation | 0.66024983 |
| 174 | MP0002163_abnormal_gland_morphology | 0.65198910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.64462051 |
| 2 | Myocardial infarction (HP:0001658) | 4.30106392 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.54407542 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 3.51972416 |
| 5 | Prostate neoplasm (HP:0100787) | 3.46238489 |
| 6 | Recurrent abscess formation (HP:0002722) | 3.42154540 |
| 7 | Abnormality of the ischium (HP:0003174) | 3.20025227 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.05778679 |
| 9 | Optic neuritis (HP:0100653) | 3.05778679 |
| 10 | Hypoplastic ischia (HP:0003175) | 3.03578165 |
| 11 | Orchitis (HP:0100796) | 2.99502055 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 2.99011935 |
| 13 | Gingivitis (HP:0000230) | 2.91747252 |
| 14 | Papillary thyroid carcinoma (HP:0002895) | 2.90148267 |
| 15 | Peritonitis (HP:0002586) | 2.89153417 |
| 16 | Arterial thrombosis (HP:0004420) | 2.85433239 |
| 17 | Absent frontal sinuses (HP:0002688) | 2.82819825 |
| 18 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.79352456 |
| 19 | Osteolytic defects of the hand bones (HP:0009699) | 2.79352456 |
| 20 | Follicular hyperkeratosis (HP:0007502) | 2.78544628 |
| 21 | Periodontitis (HP:0000704) | 2.75584678 |
| 22 | Thick nail (HP:0001805) | 2.74526505 |
| 23 | Stomatitis (HP:0010280) | 2.74178043 |
| 24 | Vascular tortuosity (HP:0004948) | 2.68205523 |
| 25 | Overgrowth (HP:0001548) | 2.65014463 |
| 26 | Myositis (HP:0100614) | 2.60265226 |
| 27 | Metaphyseal dysplasia (HP:0100255) | 2.54129671 |
| 28 | Soft skin (HP:0000977) | 2.54086928 |
| 29 | Disinhibition (HP:0000734) | 2.53258686 |
| 30 | Gingival bleeding (HP:0000225) | 2.52136216 |
| 31 | Abnormality of macrophages (HP:0004311) | 2.48289165 |
| 32 | Neonatal short-limb short stature (HP:0008921) | 2.48194574 |
| 33 | Atrophic scars (HP:0001075) | 2.44148899 |
| 34 | Fair hair (HP:0002286) | 2.43641297 |
| 35 | Submucous cleft hard palate (HP:0000176) | 2.38586989 |
| 36 | Arterial tortuosity (HP:0005116) | 2.37843012 |
| 37 | Hypoplastic labia majora (HP:0000059) | 2.36784280 |
| 38 | Limited hip movement (HP:0008800) | 2.36133945 |
| 39 | Hematochezia (HP:0002573) | 2.32027920 |
| 40 | Protrusio acetabuli (HP:0003179) | 2.29777632 |
| 41 | Esophageal varix (HP:0002040) | 2.29035732 |
| 42 | Calf muscle hypertrophy (HP:0008981) | 2.28629648 |
| 43 | Cardiovascular calcification (HP:0011915) | 2.27680306 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 2.26786497 |
| 45 | Distal lower limb amyotrophy (HP:0008944) | 2.25813227 |
| 46 | Lip pit (HP:0100267) | 2.25731871 |
| 47 | Type 1 muscle fiber predominance (HP:0003803) | 2.22623043 |
| 48 | Hyperventilation (HP:0002883) | 2.18200994 |
| 49 | Mitral stenosis (HP:0001718) | 2.18015876 |
| 50 | Hamartoma of the eye (HP:0010568) | 2.17951623 |
| 51 | Abnormality of the labia majora (HP:0012881) | 2.17453471 |
| 52 | Abnormality of the nasal septum (HP:0000419) | 2.16117564 |
| 53 | Nemaline bodies (HP:0003798) | 2.13356083 |
| 54 | Increased cerebral lipofuscin (HP:0011813) | 2.12609661 |
| 55 | Subacute progressive viral hepatitis (HP:0006572) | 2.12249805 |
| 56 | Renal cortical cysts (HP:0000803) | 2.11593767 |
| 57 | Abnormality of the calf musculature (HP:0001430) | 2.11088261 |
| 58 | Pulmonary infiltrates (HP:0002113) | 2.09504005 |
| 59 | Recurrent fungal infections (HP:0002841) | 2.08587029 |
| 60 | Delayed gross motor development (HP:0002194) | 2.08413863 |
| 61 | Cerebral aneurysm (HP:0004944) | 2.06956874 |
| 62 | Vasculitis (HP:0002633) | 2.06614100 |
| 63 | Spondylolisthesis (HP:0003302) | 2.06075043 |
| 64 | Mediastinal lymphadenopathy (HP:0100721) | 2.05487855 |
| 65 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.05043753 |
| 66 | Coronal craniosynostosis (HP:0004440) | 2.04254506 |
| 67 | Urethral obstruction (HP:0000796) | 2.03819528 |
| 68 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.03707664 |
| 69 | Mucopolysacchariduria (HP:0008155) | 2.02927196 |
| 70 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02927196 |
| 71 | Tetraparesis (HP:0002273) | 2.02836666 |
| 72 | Recurrent skin infections (HP:0001581) | 2.02483524 |
| 73 | Abnormality of the fingertips (HP:0001211) | 1.99873726 |
| 74 | Premature loss of primary teeth (HP:0006323) | 1.99663355 |
| 75 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98498373 |
| 76 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98498373 |
| 77 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98498373 |
| 78 | Coarse hair (HP:0002208) | 1.98237941 |
| 79 | Long toe (HP:0010511) | 1.97990720 |
| 80 | Muscle fiber inclusion bodies (HP:0100299) | 1.96815054 |
| 81 | Dysostosis multiplex (HP:0000943) | 1.96790021 |
| 82 | Abnormality of proline metabolism (HP:0010907) | 1.95843149 |
| 83 | Hydroxyprolinuria (HP:0003080) | 1.95843149 |
| 84 | Right ventricular cardiomyopathy (HP:0011663) | 1.93215359 |
| 85 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.92613351 |
| 86 | Abnormality of the renal cortex (HP:0011035) | 1.92422742 |
| 87 | Vacuolated lymphocytes (HP:0001922) | 1.92290652 |
| 88 | Nephritis (HP:0000123) | 1.92222181 |
| 89 | Aortic aneurysm (HP:0004942) | 1.91780932 |
| 90 | Hyporeflexia of lower limbs (HP:0002600) | 1.91153199 |
| 91 | Wormian bones (HP:0002645) | 1.90901327 |
| 92 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.90822965 |
| 93 | Hypoplastic scapulae (HP:0000882) | 1.90822965 |
| 94 | Pancreatic fibrosis (HP:0100732) | 1.90538658 |
| 95 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.90373444 |
| 96 | Thyroid carcinoma (HP:0002890) | 1.90350895 |
| 97 | Alopecia of scalp (HP:0002293) | 1.88745628 |
| 98 | Aneurysm (HP:0002617) | 1.88398988 |
| 99 | Abnormality of the frontal sinuses (HP:0002687) | 1.88360653 |
| 100 | Inappropriate behavior (HP:0000719) | 1.86560719 |
| 101 | Abnormality of the common coagulation pathway (HP:0010990) | 1.86021389 |
| 102 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.85768629 |
| 103 | Generalized hypopigmentation of hair (HP:0011358) | 1.85360220 |
| 104 | Curly hair (HP:0002212) | 1.85013036 |
| 105 | Macroorchidism (HP:0000053) | 1.84842854 |
| 106 | Pustule (HP:0200039) | 1.83946041 |
| 107 | Osteomyelitis (HP:0002754) | 1.83896205 |
| 108 | Chronic hepatic failure (HP:0100626) | 1.83115844 |
| 109 | Abnormality of the lumbar spine (HP:0100712) | 1.81532393 |
| 110 | Pulmonic stenosis (HP:0001642) | 1.80994629 |
| 111 | Acute myeloid leukemia (HP:0004808) | 1.80475061 |
| 112 | Increased connective tissue (HP:0009025) | 1.80376412 |
| 113 | Knee flexion contracture (HP:0006380) | 1.80259397 |
| 114 | Axonal loss (HP:0003447) | 1.79780731 |
| 115 | Bell-shaped thorax (HP:0001591) | 1.79778814 |
| 116 | Genital tract atresia (HP:0001827) | 1.79552800 |
| 117 | Microglossia (HP:0000171) | 1.79184898 |
| 118 | Proximal amyotrophy (HP:0007126) | 1.78784246 |
| 119 | Mitral valve prolapse (HP:0001634) | 1.78759581 |
| 120 | Lower limb amyotrophy (HP:0007210) | 1.78718874 |
| 121 | Increased density of long bones (HP:0006392) | 1.78426565 |
| 122 | Persistence of primary teeth (HP:0006335) | 1.77498041 |
| 123 | Oligodontia (HP:0000677) | 1.77382291 |
| 124 | Joint hemorrhage (HP:0005261) | 1.76563804 |
| 125 | Bone pain (HP:0002653) | 1.75468358 |
| 126 | Keratoconjunctivitis sicca (HP:0001097) | 1.74965541 |
| 127 | Thoracic kyphosis (HP:0002942) | 1.74235154 |
| 128 | Dilatation of the ascending aorta (HP:0005111) | 1.73739339 |
| 129 | Abnormal biliary tract morphology (HP:0012440) | 1.73049188 |
| 130 | Medial flaring of the eyebrow (HP:0010747) | 1.72903373 |
| 131 | Amyloidosis (HP:0011034) | 1.72670287 |
| 132 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.72543091 |
| 133 | Difficulty running (HP:0009046) | 1.72211082 |
| 134 | Drooling (HP:0002307) | 1.71449850 |
| 135 | Bifid tongue (HP:0010297) | 1.70901821 |
| 136 | Increased CSF protein (HP:0002922) | 1.70651130 |
| 137 | Entropion (HP:0000621) | 1.70019345 |
| 138 | Hypoalphalipoproteinemia (HP:0003233) | 1.69297776 |
| 139 | Volvulus (HP:0002580) | 1.69222692 |
| 140 | Increased number of teeth (HP:0011069) | 1.69204118 |
| 141 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.68520414 |
| 142 | Vascular calcification (HP:0004934) | 1.67123775 |
| 143 | Premature rupture of membranes (HP:0001788) | 1.66404282 |
| 144 | Increased corneal curvature (HP:0100692) | 1.66363976 |
| 145 | Keratoconus (HP:0000563) | 1.66363976 |
| 146 | Frequent falls (HP:0002359) | 1.66229716 |
| 147 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.66211472 |
| 148 | Natal tooth (HP:0000695) | 1.66073643 |
| 149 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.65751292 |
| 150 | Wrist flexion contracture (HP:0001239) | 1.65690923 |
| 151 | Narrow palate (HP:0000189) | 1.65620315 |
| 152 | Hypoplasia of the iris (HP:0007676) | 1.65591706 |
| 153 | Gaze-evoked nystagmus (HP:0000640) | 1.64135615 |
| 154 | Ankle contracture (HP:0006466) | 1.63755399 |
| 155 | Infantile muscular hypotonia (HP:0008947) | 1.63705409 |
| 156 | Keratoconjunctivitis (HP:0001096) | 1.63387540 |
| 157 | Hip dysplasia (HP:0001385) | 1.62812328 |
| 158 | Tubulointerstitial nephritis (HP:0001970) | 1.62809371 |
| 159 | Abnormality of the thoracic spine (HP:0100711) | 1.62116645 |
| 160 | Congenital primary aphakia (HP:0007707) | 1.61998999 |
| 161 | Hemiparesis (HP:0001269) | 1.61651041 |
| 162 | Hyperglycemia (HP:0003074) | 1.61484667 |
| 163 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.61409133 |
| 164 | Thoracolumbar scoliosis (HP:0002944) | 1.61059372 |
| 165 | Systemic lupus erythematosus (HP:0002725) | 1.60865663 |
| 166 | Small hand (HP:0200055) | 1.59668347 |
| 167 | Aortic dissection (HP:0002647) | 1.59476073 |
| 168 | Vaginal atresia (HP:0000148) | 1.59455142 |
| 169 | Autoamputation (HP:0001218) | 1.59331910 |
| 170 | Advanced eruption of teeth (HP:0006288) | 1.59194945 |
| 171 | Hyperextensible skin (HP:0000974) | 1.59170854 |
| 172 | Decreased muscle mass (HP:0003199) | 1.58699950 |
| 173 | Cupped ribs (HP:0000887) | 1.58440667 |
| 174 | Pancreatic cysts (HP:0001737) | 1.58388316 |
| 175 | Spontaneous abortion (HP:0005268) | 1.58090809 |
| 176 | True hermaphroditism (HP:0010459) | 1.57587810 |
| 177 | Deep venous thrombosis (HP:0002625) | 1.57510416 |
| 178 | Aqueductal stenosis (HP:0002410) | 1.56450957 |
| 179 | Short foot (HP:0001773) | 1.56416645 |
| 180 | Bundle branch block (HP:0011710) | 1.55637766 |
| 181 | Gait imbalance (HP:0002141) | 1.55230032 |
| 182 | Broad metatarsal (HP:0001783) | 1.54817468 |
| 183 | Astrocytoma (HP:0009592) | 1.53566978 |
| 184 | Abnormality of the astrocytes (HP:0100707) | 1.53566978 |
| 185 | Absent speech (HP:0001344) | 1.52649281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.70764226 |
| 2 | TAOK3 | 2.84591417 |
| 3 | AKT3 | 2.79391567 |
| 4 | JAK3 | 2.73914732 |
| 5 | RIPK4 | 2.68448511 |
| 6 | STK38L | 2.57731318 |
| 7 | MAP3K12 | 2.49936800 |
| 8 | LATS1 | 2.45485974 |
| 9 | TRIM28 | 2.43376409 |
| 10 | MYLK | 2.29392682 |
| 11 | JAK1 | 2.25896117 |
| 12 | TYK2 | 2.21343674 |
| 13 | FRK | 2.21151639 |
| 14 | CASK | 2.19851298 |
| 15 | PNCK | 2.15855014 |
| 16 | TTN | 2.06903631 |
| 17 | EIF2AK3 | 1.98897740 |
| 18 | TBK1 | 1.97706135 |
| 19 | RIPK1 | 1.92842048 |
| 20 | TNIK | 1.85836095 |
| 21 | IRAK3 | 1.85479195 |
| 22 | FGFR2 | 1.79589069 |
| 23 | CAMK1D | 1.77636924 |
| 24 | FGFR3 | 1.73181718 |
| 25 | MST4 | 1.72409670 |
| 26 | SIK1 | 1.71796530 |
| 27 | BMPR1B | 1.67746877 |
| 28 | PLK2 | 1.63135568 |
| 29 | STK39 | 1.60369371 |
| 30 | EPHA3 | 1.59745102 |
| 31 | MAP3K13 | 1.59077070 |
| 32 | PTK6 | 1.58277587 |
| 33 | OBSCN | 1.57050054 |
| 34 | CAMK1G | 1.50046817 |
| 35 | MAP3K2 | 1.48318738 |
| 36 | ACVR1B | 1.46839672 |
| 37 | CHUK | 1.45522147 |
| 38 | NEK9 | 1.44802823 |
| 39 | BRSK2 | 1.43283001 |
| 40 | DMPK | 1.40097168 |
| 41 | KIT | 1.38154420 |
| 42 | TRPM7 | 1.36543963 |
| 43 | IKBKE | 1.35185744 |
| 44 | ERBB4 | 1.34826591 |
| 45 | FGFR4 | 1.34512571 |
| 46 | PDGFRA | 1.29784611 |
| 47 | JAK2 | 1.26796221 |
| 48 | PDGFRB | 1.26248251 |
| 49 | EPHB1 | 1.25349447 |
| 50 | TXK | 1.25256576 |
| 51 | IKBKB | 1.23155644 |
| 52 | MAP4K2 | 1.21330938 |
| 53 | PINK1 | 1.18137222 |
| 54 | BCR | 1.15645531 |
| 55 | STK3 | 1.14903783 |
| 56 | EIF2AK1 | 1.14008269 |
| 57 | MAP3K6 | 1.13776328 |
| 58 | PIK3CA | 1.13714799 |
| 59 | WNK3 | 1.11935789 |
| 60 | PHKG2 | 1.10326796 |
| 61 | PHKG1 | 1.10326796 |
| 62 | CDK12 | 1.03842344 |
| 63 | SCYL2 | 1.02365705 |
| 64 | NLK | 1.02016232 |
| 65 | MKNK2 | 1.01830785 |
| 66 | RET | 1.01306367 |
| 67 | INSRR | 0.98980883 |
| 68 | DDR2 | 0.98911191 |
| 69 | SGK3 | 0.98909120 |
| 70 | SIK2 | 0.98880225 |
| 71 | MAP3K5 | 0.96865186 |
| 72 | TRIB3 | 0.96584733 |
| 73 | TGFBR2 | 0.95951323 |
| 74 | MST1R | 0.95430400 |
| 75 | MAPK13 | 0.92425598 |
| 76 | ROCK1 | 0.88936488 |
| 77 | HCK | 0.86268719 |
| 78 | TIE1 | 0.86228241 |
| 79 | MET | 0.85157820 |
| 80 | CSK | 0.84197804 |
| 81 | PTK2B | 0.84063419 |
| 82 | IRAK4 | 0.83942949 |
| 83 | FGFR1 | 0.83915596 |
| 84 | STK24 | 0.83756798 |
| 85 | TAOK1 | 0.83102795 |
| 86 | LIMK1 | 0.82684622 |
| 87 | PRKCH | 0.81954026 |
| 88 | MAP3K3 | 0.81771474 |
| 89 | SGK2 | 0.81312498 |
| 90 | ZAP70 | 0.78045044 |
| 91 | CDK6 | 0.76736698 |
| 92 | WNK1 | 0.76210264 |
| 93 | ERN1 | 0.75674937 |
| 94 | GRK7 | 0.75466972 |
| 95 | GRK1 | 0.75235375 |
| 96 | EGFR | 0.73924097 |
| 97 | HIPK2 | 0.73402326 |
| 98 | CDK9 | 0.73056340 |
| 99 | WNK4 | 0.72755681 |
| 100 | BRD4 | 0.72404811 |
| 101 | NUAK1 | 0.71450812 |
| 102 | LCK | 0.70999809 |
| 103 | STK38 | 0.70972368 |
| 104 | ABL2 | 0.69802911 |
| 105 | KSR2 | 0.69258345 |
| 106 | MAP3K7 | 0.69203776 |
| 107 | OXSR1 | 0.68697058 |
| 108 | PTK2 | 0.67292166 |
| 109 | ABL1 | 0.65655941 |
| 110 | PAK2 | 0.65054245 |
| 111 | SGK1 | 0.64656864 |
| 112 | RPS6KA4 | 0.64651053 |
| 113 | FER | 0.64220294 |
| 114 | BMX | 0.63902892 |
| 115 | ITK | 0.63528766 |
| 116 | PIK3CG | 0.61715971 |
| 117 | BMPR2 | 0.61709192 |
| 118 | MAP2K3 | 0.61666622 |
| 119 | ADRBK1 | 0.60507586 |
| 120 | PRKCQ | 0.60399449 |
| 121 | CSNK1G1 | 0.60312836 |
| 122 | IGF1R | 0.59878337 |
| 123 | TGFBR1 | 0.58950230 |
| 124 | MAP3K1 | 0.58361716 |
| 125 | FGR | 0.56311408 |
| 126 | PRKAA2 | 0.55759330 |
| 127 | NEK1 | 0.55603547 |
| 128 | MELK | 0.55281821 |
| 129 | MAP2K4 | 0.53400664 |
| 130 | NTRK1 | 0.53360463 |
| 131 | MARK3 | 0.52939686 |
| 132 | PRKG1 | 0.52433197 |
| 133 | MTOR | 0.51763533 |
| 134 | CSNK1G2 | 0.50580827 |
| 135 | ERBB3 | 0.50325574 |
| 136 | MUSK | 0.50275356 |
| 137 | LATS2 | 0.50151418 |
| 138 | TEC | 0.49740910 |
| 139 | KSR1 | 0.49277767 |
| 140 | PLK4 | 0.49022389 |
| 141 | PLK3 | 0.48177285 |
| 142 | NTRK3 | 0.46866542 |
| 143 | EPHB2 | 0.46361832 |
| 144 | PBK | 0.44108288 |
| 145 | GSK3A | 0.43694835 |
| 146 | ROCK2 | 0.42332257 |
| 147 | EIF2AK2 | 0.41771133 |
| 148 | CAMKK2 | 0.41707198 |
| 149 | STK10 | 0.41540991 |
| 150 | LMTK2 | 0.40115388 |
| 151 | MAPKAPK3 | 0.39949628 |
| 152 | PRKCE | 0.39732031 |
| 153 | PDK1 | 0.39388071 |
| 154 | CAMK2D | 0.38757565 |
| 155 | PRKACB | 0.38458176 |
| 156 | INSR | 0.38275005 |
| 157 | WEE1 | 0.38188855 |
| 158 | MAP3K4 | 0.37896605 |
| 159 | PAK3 | 0.37871035 |
| 160 | MAPK10 | 0.37249863 |
| 161 | CAMK2A | 0.37149218 |
| 162 | ATM | 0.36638918 |
| 163 | PDK2 | 0.36242219 |
| 164 | PRKAA1 | 0.35927709 |
| 165 | SGK494 | 0.35914044 |
| 166 | SGK223 | 0.35914044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.11028254 |
| 2 | Circadian rhythm_Homo sapiens_hsa04710 | 2.47852752 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.04968258 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.98523820 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.83088574 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.82925042 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.81984809 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81824340 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.79540311 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.78205059 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.77249164 |
| 12 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.72040075 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.71711119 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68102843 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.58669637 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53761636 |
| 17 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.53061744 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.52397719 |
| 19 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.52168556 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.46574246 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.46299415 |
| 22 | * Tuberculosis_Homo sapiens_hsa05152 | 1.45630999 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.45528019 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.42747255 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42470826 |
| 26 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.37724372 |
| 27 | Insulin secretion_Homo sapiens_hsa04911 | 1.30550193 |
| 28 | Tight junction_Homo sapiens_hsa04530 | 1.30320538 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.29710695 |
| 30 | Amoebiasis_Homo sapiens_hsa05146 | 1.28831954 |
| 31 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.26720380 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24230588 |
| 33 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.22002156 |
| 34 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.21001115 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.20593577 |
| 36 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.19784904 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19444678 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19252863 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.17602179 |
| 40 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.17415577 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.17070901 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.14907677 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14072765 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12142018 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.12024172 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11186318 |
| 47 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.10984086 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.10141307 |
| 49 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.08541279 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.08294601 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 1.07466848 |
| 52 | Insulin resistance_Homo sapiens_hsa04931 | 1.07229028 |
| 53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06984511 |
| 54 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.05766224 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.05340529 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.03843156 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.03196034 |
| 58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.03000446 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.02966606 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.00676025 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00468696 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99583604 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99147820 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.96989516 |
| 65 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96652405 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96495175 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96007797 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94924426 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94796716 |
| 70 | * Phagosome_Homo sapiens_hsa04145 | 0.92331044 |
| 71 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.91805905 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91151649 |
| 73 | Salivary secretion_Homo sapiens_hsa04970 | 0.90171980 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90065493 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.89344879 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.88722894 |
| 77 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.88615709 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87668393 |
| 79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87661751 |
| 80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87621955 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87533717 |
| 82 | Circadian entrainment_Homo sapiens_hsa04713 | 0.85905359 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.85720141 |
| 84 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.85310715 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85113186 |
| 86 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85084799 |
| 87 | Focal adhesion_Homo sapiens_hsa04510 | 0.82952589 |
| 88 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82477596 |
| 89 | Long-term depression_Homo sapiens_hsa04730 | 0.81895110 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.81787094 |
| 91 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.80727544 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.80415271 |
| 93 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80330849 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79944525 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79115314 |
| 96 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78761252 |
| 97 | Phototransduction_Homo sapiens_hsa04744 | 0.77449150 |
| 98 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.77349621 |
| 99 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.76912056 |
| 100 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.76774362 |
| 101 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76758140 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.75996410 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75234685 |
| 104 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.75001185 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74794334 |
| 106 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74195226 |
| 107 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.73917235 |
| 108 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.73705003 |
| 109 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.72776173 |
| 110 | Axon guidance_Homo sapiens_hsa04360 | 0.72366223 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72254378 |
| 112 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.71848911 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.71349635 |
| 114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70870712 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.70242198 |
| 116 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.70125668 |
| 117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.69958376 |
| 118 | Basal transcription factors_Homo sapiens_hsa03022 | 0.69952664 |
| 119 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69656783 |
| 120 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69002834 |
| 121 | Glioma_Homo sapiens_hsa05214 | 0.68880684 |
| 122 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.68056947 |
| 123 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67557278 |
| 124 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67137227 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66960870 |
| 126 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.66470045 |
| 127 | Lysine degradation_Homo sapiens_hsa00310 | 0.65579197 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65138145 |
| 129 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64593787 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64081332 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64067793 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64064168 |
| 133 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63666495 |
| 134 | Melanogenesis_Homo sapiens_hsa04916 | 0.62297497 |
| 135 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.60572338 |
| 136 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59612478 |
| 137 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59073884 |
| 138 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.58984045 |
| 139 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58341219 |
| 140 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57824515 |
| 141 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.57707095 |
| 142 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56910769 |
| 143 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56128668 |
| 144 | Taste transduction_Homo sapiens_hsa04742 | 0.55291152 |
| 145 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55248471 |
| 146 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54849102 |
| 147 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54715838 |
| 148 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54084929 |
| 149 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54021821 |
| 150 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53543270 |
| 151 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53425536 |
| 152 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52494236 |
| 153 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52312334 |
| 154 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51979505 |
| 155 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51550763 |
| 156 | Melanoma_Homo sapiens_hsa05218 | 0.51165053 |
| 157 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50343912 |
| 158 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49769086 |
| 159 | Pathways in cancer_Homo sapiens_hsa05200 | 0.49629180 |
| 160 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49551276 |
| 161 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49540710 |
| 162 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49312265 |
| 163 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48755213 |
| 164 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48516182 |
| 165 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48413320 |
| 166 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.48184537 |
| 167 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47832331 |
| 168 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47489279 |
| 169 | Bile secretion_Homo sapiens_hsa04976 | 0.46574297 |
| 170 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46545289 |
| 171 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45635633 |
| 172 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43736422 |
| 173 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43573240 |
| 174 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42967246 |

